BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

TPG-Backed Quintiles, Inc. (QTRN) Outlines $790 Million Price in IPO


4/26/2013 8:25:47 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Quintiles Transnational Holdings Inc., the biggest provider of testing services to drugmakers, filed to raise about $790 million in a U.S. initial public offering. The company and its shareholders, including TPG Capital and Bain Capital LLC, are offering 19.7 million shares for $36 to $40 apiece, according to a regulatory filing today. That would be equal to about 15 percent of the shares outstanding. At the midpoint of the range, the market value for Quintiles would be about $4.9 billion, according to data compiled by Bloomberg. It joins companies including ING U.S. Inc. that are selling shares this year after U.S. stocks have risen to record levels and volatility in the market has subsided.

Help employers find you! Check out all the jobs and post your resume.


Read at Bloomberg
Read at Nasdaq
Read at Wall Street Journal

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES